Down 10.3% in 4 Weeks, Here's Why You Should You Buy the Dip in Boston Scientific (BSX)

Group 1 - Boston Scientific (BSX) has experienced a downtrend with a stock decline of 10.3% over the past four weeks, indicating significant selling pressure [1] - The stock is currently in oversold territory, with an RSI reading of 29.83, suggesting a potential trend reversal is imminent [5] - Analysts are in strong agreement regarding BSX's ability to report better earnings than previously predicted, leading to a consensus EPS estimate increase of 0% over the last 30 days [7] Group 2 - The Zacks Rank for BSX is 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate revisions and EPS surprises, indicating a strong potential for a turnaround [8] - The Relative Strength Index (RSI) is a key technical indicator used to identify oversold conditions, oscillating between zero and 100, with readings below 30 typically indicating oversold status [2][3]